Anthony Cuomo
Pulmonary Disease · San Diego, CANPI 1356440465
Payments from drug & device makers
Across 227 payments — averaging $18.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$600
- AstraZeneca$589
- Boehringer Ingelheim$513
- Regeneron Healthcare Solutions, Inc.$242
- Philips North America LLC$226
- Actelion Pharmaceuticals US, Inc.$195
- plus $2K from 29 others
What the payments were for
- Food & beverage$4,080100%
- Education$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 28 | $600 |
| AstraZeneca | 34 | $589 |
| Boehringer Ingelheim | 26 | $513 |
| Regeneron Healthcare Solutions, Inc. | 9 | $242 |
| Philips North America LLC | 23 | $226 |
| Actelion Pharmaceuticals US, Inc. | 12 | $195 |
| Sanofi | 10 | $189 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $173 |
| Insmed, Inc. | 7 | $158 |
| Mylan Specialty L.p. | 5 | $112 |
| Grifols USA, LLC | 5 | $97 |
| Pfizer | 5 | $81 |
| Gilead | 3 | $72 |
| Merck | 4 | $71 |
| Sunovion Pharmaceuticals Inc. | 9 | $62 |
| Baxter Healthcare | 2 | $60 |
| Genentech USA, Inc. | 3 | $57 |
| Paratek Pharmaceuticals, Inc. | 3 | $53 |
| Johnson & Johnson | 3 | $51 |
| Advanced Respiratory, Inc | 2 | $50 |
| Sanofi Pasteur Inc. | 3 | $46 |
| Amgen | 2 | $45 |
| Hospira, Inc. | 2 | $44 |
| Circassia Inc. | 3 | $37 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Resmed Corp | 2 | $36 |
| Electromed, Inc. | 2 | $32 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $30 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Harmony Biosciences LLC | 1 | $23 |
| Melinta Therapeutics, LLC | 1 | $21 |
| Pulmonx Corporation | 2 | $19 |
| Vyera Pharmaceuticals, LLC | 1 | $19 |
| Pentax Of America, Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $13 |
How this compares
$4,096 in reported general payments places this provider in the 60th percentile of 1,261 pulmonary disease providers in California.
Other pulmonary disease in San Diego
- Edward FedermanSan Diego$3.6M
- David PochSan Diego$1.5M
- Shari BrazinskySan Diego$522K
- Samir MakaniSan Diego$371K
- George ChengSan Diego$309K
- Toby MaherLos Angeles$27.6M
- David PhamWestminster$5.9M
- Andrew WachtelLos Angeles$5.9M
- Aaron WeinbergIrvine$5.1M
- Michael RothLos Angeles$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.